Zaher Srour, MD
Otolaryngic Allergy · Hanover, PANPI 1194928069
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 91.2% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 29 manufacturers, the largest accounting for just 19.6% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $1,030, 2.3 times the $454 reported in 2019.
Across 194 payments — averaging $21.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Regeneron Healthcare Solutions, Inc.$825
- Optinose US, Inc.$660
- AstraZeneca$572
- GSK$291
- Sanofi$270
- Sanofi-aventis U.S. LLC$253
- plus $1K from 23 others
What the payments were for
- Food & beverage$3,84391%
- Education$3709%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 38 | $825 |
| Optinose US, Inc. | 39 | $660 |
| AstraZeneca | 29 | $572 |
| GSK | 12 | $291 |
| Sanofi | 12 | $270 |
| Sanofi-aventis U.S. LLC | 3 | $253 |
| Kaleo, Inc. | 11 | $181 |
| Acclarent, Inc | 4 | $174 |
| Intersect ENT, Inc. | 4 | $154 |
| Amgen | 6 | $125 |
| Phathom Pharmaceuticals, Inc. | 4 | $89 |
| Stryker | 3 | $81 |
| AbbVie | 2 | $67 |
| Novartis | 3 | $57 |
| Aerin Medical Inc. | 4 | $51 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| Pfizer | 2 | $38 |
| ARS Pharmaceuticals Operations, Inc. | 2 | $36 |
| Medtronic | 1 | $35 |
| Aimmune Therapeutics, Inc. | 2 | $28 |
| Merck | 2 | $28 |
| Neurent Medical Limited | 1 | $25 |
| Ambu Inc. | 2 | $23 |
| Integra Lifesciences Corporation | 1 | $23 |
| Arrinex, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $18 |
| Paratek Pharmaceuticals, Inc. | 1 | $18 |
| Merz Pharmaceuticals, LLC | 1 | $18 |
| Alk-abello, Inc | 1 | $15 |
How this compares
Too few otolaryngic allergy providers in Pennsylvaniato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 29 | $111,759 |
| Fluticasone Propionate | 719 | $11,964 |
| Montelukast Sodium | 669 | $7,926 |
| Epinephrine | 29 | $5,294 |
| CefuroximeCefuroxime Axetil | 123 | $4,068 |
| Cefdinir | 297 | $3,916 |
| Mupirocin | 426 | $3,902 |
| Omeprazole | 307 | $3,530 |
| Clobetasol Propionate | 140 | $3,318 |
| Ofloxacin | 102 | $3,245 |
| Ipratropium Bromide | 62 | $2,746 |
| Famotidine | 218 | $2,599 |
| Acetic Acid | 133 | $2,263 |
| Lidocaine-PrilocaineLidocaine/Prilocaine | 125 | $1,190 |
| Azelastine Hcl | 23 | $796 |
Paid to pharmacies, not to this prescriber.
Other otolaryngic allergy in Hanover
- Elina ToskalaPhiladelphia$108K
- Alexander KeszeliExton$3K
- Mohammad AkbarPottsville$2K
- Louis MariottiKingston$1K
- Sidney LipmanErie$958
- Jack AnonErie$642
- Allison HarbartJohnstown$280
- David RogersonJohnstown$80
- Kristin BrantJohnstown$15
- David ArmstrongJohnstown$13
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.